China Sky One Medical (中国天字一号医药公司) announced that the R&D behind its Sudden Cardiac Death (SCD) Early Examination Kit was examined by the Heilongjiang Bureau of Science and Technology, which concluded that the research was reliably conducted. The decision allows China Sky One to begin clinical trials on its SCD Kit. In 2008, Prof. Baofeng Yang, Principal of Harbin Medical University and Chief Scientist of Chinese National 973 Project, found a positive correlation between the concentration of a substance called "MicroRNA-1" in human blood and the occurrence of SCD. More details...

Stock Symbol: (NSDQ: CSKI)